Recent history suggests that for all its global proliferation, technology rests on a few critical R&D and commercialization hubs: choke points. Consider these points of remarkable concentration: Xerox and Apple for interfaces, say, or DARPA and MIT, or Genentech, Monsanto, Stanford, and UCSF for genetic engineering. It’s remarkable how this legacy is only slowly disappearing.
